|
Multivariate logistic models (complete cases only) |
||||
| Model 1 outcome: 'delayed or avoided' |
Model 2 outcome: 'delayed or avoided' subgroup with chronic disease |
Model 3 outcome: 'delayed' |
Model 4 outcome: 'avoided' |
|
|
|
||||
| N |
7,198 |
3,542 |
7,198 |
7,198 |
| odds ratio (95% CI) |
||||
| Age (years) under 30 |
3.46 (2.72–4.39) |
3.35 (2.28–4.94) |
1.46 (1.13–1.90) |
5.44 (3.69–8.01) |
| Gender male |
0.98 (0.89–1.09) |
1.13 (0.97–1.31) |
0.90 (0.80–1.00) |
1.12 (0.98–1.27) |
| Per capita Income (Euro) |
||||
| < 600 |
2.31 (1.98–2.70) |
2.45 (1.90–3.15) |
1.45 (1.22–1.72) |
2.20 (1.81–2.68) |
| 600–800 |
1.73 (1.48–2.01) |
1.81 (1.45–2.28) |
1.41 (1.19–1.67) |
1.59 (1.29–1.96) |
| 800–1,000 |
1.31 (1.11–1.55) |
1.46 (1.14–1.87) |
1.24 (1.03–1.49) |
1.20 (0.95–1.52) |
| 1,000–1,300 |
1.39 (1.19–1.63) |
1.47 (1.17–1.85) |
1.27 (1.06–1.51) |
1.29 (1.04–1.61) |
| HAWa little |
1.28 (1.05–1.57) |
1.94 (1.38–2.74) |
0.68 (0.53–0.87) |
2.09 (1.66–2.63) |
| SAHb very good |
1.13 (0.95–1.34) |
1.22 (0.93–1.61) |
1.17 (0.97–1.41) |
1.02 (0.81–1.29) |
| Chronic disease no |
1.13 (0.99–1.28) |
- |
0.84 (0.73–0.96) |
1.53 (1.30–1.80) |
| Maximum co-payment 1% no |
1.77 (1.50–2.09) |
1.71 (1.43–2.04) |
1.57 (1.31–1.88) |
1.59 (1.22–2.08) |
| survey spring 2006 |
1.95 (1.65–2.31) |
1.88 (1.47–2.42) |
2.56 (2.12–3.10) |
0.86 (0.69–1.07) |
| c-value |
0.69 |
0.70 |
0.62 |
0.72 |
| H/Lc p-value |
0.49 |
0.43 |
0.45 |
0.31 |
| Pseudo R2 Nagelkerke |
0.14 |
0.13 |
0.10 |
0.15 |
| Pseudo R2 McFadden |
0.08 |
0.08 |
0.03 |
0.10 |
|
a Health awareness, b Self assessed health, c Hosmer Lemeshow test Comparison groups: age: over 70; gender: female; per capita income: > 1,300 Euro; HAW: strong; SAH: poor; chronic disease: yes; max. co-payment of 1%: yes; survey: spring 2004 | ||||
Rückert et al. BMC Health Services Research 2008 8:232 doi:10.1186/1472-6963-8-232 |
||||